milrinone has been researched along with Disease Exacerbation in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Milrinone-treated patients with ischemic heart disease and chronic kidney disease (CKD) at stage ≥ 4 presented with greater incidence of MACCE (log rank; P < 0." | 5.56 | Comparing the effects of milrinone and olprinone in patients with congestive heart failure. ( Dobashi, S; Fujii, T; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Nakanishi, R; Oka, T; Watanabe, I, 2020) |
| "Milrinone was most effective at reducing mortality and had the lowest incidence of adverse reactions." | 2.66 | Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock. ( Chen, X; Lei, J; Liao, X; Qian, L; Zhang, S, 2020) |
| "Milrinone-treated patients with ischemic heart disease and chronic kidney disease (CKD) at stage ≥ 4 presented with greater incidence of MACCE (log rank; P < 0." | 1.56 | Comparing the effects of milrinone and olprinone in patients with congestive heart failure. ( Dobashi, S; Fujii, T; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Nakanishi, R; Oka, T; Watanabe, I, 2020) |
| "Myocarditis is a common cause for acute heart failure in the pediatric population." | 1.51 | Does myocardial strain remain abnormal long after normalization of ejection fraction in patients with acute myocarditis? ( Bourget, L; Garg, A; Manalo, R; Swaminathan, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawkes, MA | 1 |
| Hlavnicka, AA | 1 |
| Wainsztein, NA | 1 |
| Dobashi, S | 1 |
| Watanabe, I | 1 |
| Nakanishi, R | 1 |
| Hisatake, S | 1 |
| Kiuchi, S | 1 |
| Kabuki, T | 1 |
| Oka, T | 1 |
| Fujii, T | 1 |
| Ikeda, T | 1 |
| Kelly, J | 1 |
| Cheng, J | 1 |
| Malloy, R | 1 |
| Lupi, K | 1 |
| Liao, X | 1 |
| Qian, L | 1 |
| Zhang, S | 1 |
| Chen, X | 1 |
| Lei, J | 1 |
| Manalo, R | 1 |
| Bourget, L | 1 |
| Garg, A | 1 |
| Swaminathan, S | 1 |
| Chi, NH | 1 |
| Huang, SC | 1 |
| Yu, HY | 1 |
| Chen, YS | 1 |
| Wang, SS | 1 |
| White, M | 1 |
| Ducharme, A | 1 |
| Ibrahim, R | 1 |
| Whittom, L | 1 |
| Lavoie, J | 1 |
| Guertin, MC | 1 |
| Racine, N | 1 |
| He, Y | 1 |
| Yao, G | 1 |
| Rouleau, JL | 1 |
| Schiffrin, EL | 1 |
| Touyz, RM | 1 |
| Cripe, LH | 1 |
| Barber, BJ | 1 |
| Spicer, RL | 1 |
| Wong, BL | 1 |
| Weidner, N | 1 |
| Benson, DW | 1 |
| Markham, LW | 1 |
1 review available for milrinone and Disease Exacerbation
| Article | Year |
|---|---|
Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock.
Topics: Aged; Disease Progression; Dobutamine; Dopamine; Epinephrine; Female; Hemodynamics; Humans; Male; Mi | 2020 |
1 trial available for milrinone and Disease Exacerbation
| Article | Year |
|---|---|
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
Topics: Biomarkers; C-Reactive Protein; Cardiotonic Agents; Case-Control Studies; Cell Adhesion Molecules; C | 2006 |
6 other studies available for milrinone and Disease Exacerbation
| Article | Year |
|---|---|
Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone.
Topics: Adult; Angiography, Digital Subtraction; Aphasia, Broca; Brain Edema; Cerebral Hemorrhage; Computed | 2020 |
Comparing the effects of milrinone and olprinone in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Cardiotonic Agents; Disease Progression; Female; Heart Failure; Hospitaliza | 2020 |
Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
Topics: Aged; Cardiotonic Agents; Cause of Death; Disease Progression; Dobutamine; Female; Heart Failure; Hu | 2020 |
Does myocardial strain remain abnormal long after normalization of ejection fraction in patients with acute myocarditis?
Topics: Acute Disease; Adolescent; Atrioventricular Block; Cardiotonic Agents; Disease Progression; Echocard | 2019 |
Application of papillary muscle sling concept in an infant as a biological bridge to transplantation.
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Combined Modality Therapy; Disease Progression; Heart F | 2005 |
Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Disease Progression; Dobutamine; Dose-Response | 2006 |